Oncology lobby group pushes for PBS pan-tumour subsidies

A new oncology lobby group supported by the pharma industry says that at least 3,500 patients are self-funding non-PBS listed cancer medicines at an average cost of $60,000 annually. The National Oncology Alliance (NOA) says the figures from a “data on file” survey of oncologists, make a strong case for reform of the Pharmaceutical Benefits ...

Already a member?

Login to keep reading.

© 2022 the limbic